Proofpoint, Inc. et al v. Vade Secure, Incorporated et al

  1. September 06, 2023

    Proofpoint Denied Fees For $14M IP Verdict Against Rival

    A California federal judge denied Tuesday software company Proofpoint's attorney fee request for scoring a $14 million trade secret theft verdict against an ex-executive and a rival that hired him, finding that the evidence supporting the jury's willful misappropriation finding is minimal "at best" and not enough to warrant fees.

  2. July 11, 2023

    Judge Finds Ex-Proofpoint VP Owes $1 In Trade Secrets Suit

    A California federal judge has found that a former employee of a unit of software company Proofpoint Inc. doesn't have to pony up the $480,000 a jury said he owed for allegedly breaching a contract he had with his former employer, which had been part of a nearly $14 million jury verdict.

  3. April 19, 2023

    Proofpoint Loses Bid To Grow $14M Trade Secret Verdict

    A California federal judge has refused cybersecurity firm Proofpoint Inc.'s bid to undo various aspects of a jury's decision that it was entitled to about $14 million after finding that a former employee and a French technology company misappropriated most of the trade secrets at issue in a suit.

  4. October 29, 2021

    Proofpoint Bid To Double $14M Verdict Meets Skeptical Judge

    A California federal judge expressed skepticism Friday at cybersecurity firm Proofpoint Inc.'s bid for exemplary damages that would nearly double a $14 million verdict after a jury found Vade Secure maliciously stole Proofpoint's trade secrets, saying she's struggling to see how the jury reached its finding that Vade Secure acted with malice.

  5. August 23, 2021

    Proofpoint Entitled To $14M In Trade Secrets Case, Jury Says

    A California federal jury has said Proofpoint Inc. was entitled to about $14 million after finding that a former employee and a French technology company misappropriated most of the trade secrets at issue in a suit relating to cybersecurity.

  6. July 08, 2021

    IP Forecast: Daiichi Sankyo Unit Takes Drug Rival To A Jury

    Attorneys who are vaccinated will be allowed to go maskless before a jury on Monday in a Daiichi Sankyo unit's patent suit in California federal court alleging Novartis is infringing its billion-dollar skin cancer treatment. Here's a look at that case — plus all the other major intellectual property matters on deck in the coming week.